SVB Securities Stock Recommendations and Price Targets

This is a list of recent ratings by SVB Securities.

Date	Company Name	Action	Current Price	Price Target	Rating
8/15/2023	DMRA Damora Therapeutics, Inc. Common Stock	Downgrade	$21.00		Outperform ➝ Market Perform
8/15/2023	DSGN Design Therapeutics	Downgrade	$12.00	$6.00	Outperform ➝ Market Perform
8/15/2023	CNTA Centessa Pharmaceuticals	Boost Price Target	$40.00	$6.00 ➝ $11.00	Outperform ➝ Outperform
8/15/2023	CYTK Cytokinetics	Initiated Coverage	$78.00	$58.00	Outperform
8/8/2023	RLAY Relay Therapeutics	Initiated Coverage	$16.00		Outperform
8/8/2023	QTRX Quanterix	Upgrade	$3.00	$30.00	Market Perform ➝ Outperform
8/8/2023	EXEL Exelixis	Initiated Coverage	$52.00	$18.00	Market Perform
8/8/2023	IDYA IDEAYA Biosciences	Initiated Coverage	$31.00	$33.00	Outperform
8/8/2023	NUVL Nuvalent	Initiated Coverage	$123.00	$42.00	Market Perform
8/4/2023	NVCR NovoCure	Initiated Coverage	$18.00	$51.00	Outperform
7/26/2023	BLTE Belite Bio	Initiated Coverage	$148.00	$25.00	Outperform
7/24/2023	NBIX Neurocrine Biosciences	Upgrade	$159.00	$115.00 ➝ $125.00	Market Perform ➝ Outperform
7/13/2023	CYRX CryoPort	Downgrade	$15.00	$30.00 ➝ $10.00	Outperform ➝ Market Perform
7/10/2023	BMY Bristol Myers Squibb	Initiated Coverage	$55.00	$66.00	Market Perform
6/26/2023	MLTX MoonLake Immunotherapeutics	Boost Price Target	$19.00	$28.00 ➝ $56.00